Combined targeting of cholangiocytes and activated stromal cells with a BH3 mimetic ameliorates fibrosis in a mouse model of PSC
Anja Moncsek(University Hospital of Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Steven P. O’Hara(Mayo Clinic in Arizona), Beat Müllhaupt(University Hospital of Zurich), N. F. LaRusso, P Valli(University Hospital Zurich), Achim Weber(University Hospital of Zurich), Camille Zuber(University Hospital Zurich), Eleonora Patsenker(University Hospital of Zurich), CD Fingas, Patrick L. Splinter(Mayo Clinic in Arizona)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k